Insider Trading & Ownership - Cole Hugh M

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Cole Hugh M
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2023-01-09
Sale		2023-01-11
8:29 pm		Jounce Therapeutics Inc.JNCECole Hugh M
Chief Operating Officer		16,634$1.111$18,481110,082
(Direct)		View
2022-01-07
Sale		2022-01-11
8:55 pm		Jounce Therapeutics Inc.JNCECole Hugh M
Chief Business Officer		9,673$6.883$66,58064,216
(Direct)		View
2021-01-22
Sale		2021-01-25
5:36 pm		Jounce Therapeutics Inc.JNCECole Hugh M
Chief Business Officer		18,000$11.95$215,100141,689
(Direct)		View
2021-01-07
Sale		2021-01-11
06:19 am		Jounce Therapeutics Inc.JNCECole Hugh M
Chief Business Officer		6,219$6.8889$42,84255,189
(Direct)		View
2020-08-14
Sale		2020-08-18
8:29 pm		Jounce Therapeutics Inc.JNCECole Hugh M
Chief Business Officer		2,182$4.7096$10,27661,408
(Direct)		View
2020-01-07
Sale		2020-01-10
08:53 am		Jounce Therapeutics Inc.JNCECole Hugh M
Chief Business Officer		2,624$7.78$20,41533,590
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2024-06-05
Option Award		2024-06-06
4:05 pm		N/A
2034-06-04		Astria Therapeutics Inc.ATXSCole Hugh M
Director		14,100$014,100
(Direct)		View
2023-06-02
Option Award		2023-06-06
08:05 am		N/A
2033-06-01		Astria Therapeutics Inc.ATXSCole Hugh M
Director		14,100$014,100
(Direct)		View
2022-08-01
Option Award		2022-08-03
8:29 pm		N/A
2032-08-01		Jounce Therapeutics Inc.JNCECole Hugh M
Chief Operating Officer		60,000$0166,716
(Direct)		View
2022-06-09
Option Award(A)		2022-06-21
08:32 am		N/A
2032-06-08		Astria Therapeutics Inc.ATXSCole Hugh M
Director		8,333$08,333
(Direct)		View
2022-06-09
Option Award		2022-06-09
5:57 pm		N/A
2032-06-08		Astria Therapeutics Inc.ATXSCole Hugh M
Director		8,333$08,333
(Direct)		View
2022-02-01
Option Award(A)		2022-03-17
8:50 pm		N/A
2032-02-01		Jounce Therapeutics Inc.JNCECole Hugh M
Chief Business Officer		85,000$085,000
(Direct)		View
2022-02-01
Option Award		2022-02-03
7:38 pm		N/A
2032-02-01		Jounce Therapeutics Inc.JNCECole Hugh M
Chief Business Officer		127,500$0191,716
(Direct)		View
2021-06-02
Option Award		2021-06-02
7:14 pm		N/A
2031-06-01		CATABASIS PHARMACEUTICALS INCCATBCole Hugh M
Director		100,000$0100,000
(Direct)		View
2021-02-01
Option Award		2021-02-03
5:45 pm		N/A
N/A		Jounce Therapeutics Inc.JNCECole Hugh M
Chief Business Officer		26,700$0127,289
(Direct)		View
2021-02-01
Option Award		2021-02-03
5:45 pm		N/A
2031-02-01		Jounce Therapeutics Inc.JNCECole Hugh M
Chief Business Officer		53,400$11.89127,289
(Direct)		View
2021-01-22
Exercise		2021-01-25
5:36 pm		N/A
2029-02-01		Jounce Therapeutics Inc.JNCECole Hugh M
Chief Business Officer		10,000$0141,689
(Direct)		View
2021-01-22
Exercise		2021-01-25
5:36 pm		N/A
N/A		Jounce Therapeutics Inc.JNCECole Hugh M
Chief Business Officer		5,000$4.4141,689
(Direct)		View
2021-01-22
Exercise		2021-01-25
5:36 pm		N/A
N/A		Jounce Therapeutics Inc.JNCECole Hugh M
Chief Business Officer		5,000$6.55141,689
(Direct)		View
2020-06-11
Option Award		2020-06-12
11:56 am		N/A
2030-06-10		CATABASIS PHARMACEUTICALS INCCATBCole Hugh M
Director		7,500$07,500
(Direct)		View
2020-02-03
Option Award		2020-02-04
9:01 pm		N/A
2030-02-03		Jounce Therapeutics Inc.JNCECole Hugh M
Chief Business Officer		90,000$0123,590
(Direct)		View
(A) Indicate amendment filing.